Delivery Order SPE2DB25D7068-SPE2DB25FTXFR
- Not listed
- The Defense Logistics Agency awarded a $2,892.00 delivery order to AmerisourceBergen Drug Corp for Jolessa 0.15 mg–0.03 mg tablets (91-count supply) on July 21, 2025, with an ultimate completion date of July 22, 2025. This competitively awarded, firm fixed-price delivery order was placed under a child contract vehicle without set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as a prime pharmaceutical distributor and critical vendor for federal...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $4,336.95 to AmerisourceBergen Drug Corp for the supply of Jolessa 0.15 mg-0.03 mg tablets (91 count) under a firm fixed-price contract. The delivery order, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, carries no set-aside designation and was competitively awarded. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for pharmaceutical products on September 24, 2025, with an ultimate completion date of September 25, 2025. The contract covers the supply of Jolessa 0.15 mg-0.03 mg tablets (91-count), a hormonal contraceptive medication, with a ceiling value of $1,545.28. This delivery order is issued under a firm fixed-price arrangement with no set-aside designation, indicating competitive award to the qualified vendor. The...
- This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $237.23 to Amerisourcebergen Drug Corporation for the supply of 4561522540 JOLESSA 0.15 MG-0.03 MG TABLET 91S. As the prime contractor, Amerisourcebergen Drug Corporation will deliver the requested pharmaceutical products from its place of performance in Conshohocken, Pennsylvania within the period of performance between July 17-18, 2023. The Defense Logistics Agency utilizes numerous contracts to support the...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,136.93 by the Defense Logistics Agency (DLA) on October 31, 2025, for the supply of Jolessa Tabs 3X 91S, a hormonal contraceptive medication. The contract is a firm fixed-price delivery order with an ultimate completion date of December 1, 2025, and was awarded on a competitive basis without a set-aside designation. This delivery order...
- This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
- The Defense Logistics Agency awarded a $110,060 firm fixed price delivery order to Amerisourcebergen Drug Corporation for the supply of 91 units of 0.15 mg-0.03 mg Jolessa tablets. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen will deliver the contraceptive products under the terms of the delivery order for use at military treatment facilities in the Philadelphia area. Performance will take place at the contractor's facility in Conshohocken, Pennsylvania,...
- SPE2DB25D7068Indefinite Delivery Contract
- SPE2DB25D7068-SPE2DB25FTXFRDelivery Order
The Defense Logistics Agency awarded a $1,867.56 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Jolessa 0.15 mg-0.03 mg tablets (91-count). This non-set-aside contract, issued on July 11, 2025, with an ultimate completion date of July 14, 2025, represents a small-value pharmaceutical procurement supporting federal medical supply requirements. The place of performance is listed as Conshohocken, PA 19428, where AmerisourceBergen Drug Corp maintains its corporate office. This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. This prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The delivery order exemplifies the company's role as a critical pharmaceutical vendor for the Defense Health Agency and other federal healthcare systems, fulfilling routine medical supply needs through the competitive contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 7/11/25 |